Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

计划入组 3,939 人 · 首次发布于 2008 年 10 月 15 日

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

计划入组 500 人 · 首次发布于 2014 年 5 月 23 日

Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

计划入组 3,338 人 · 首次发布于 2008 年 9 月 9 日

T-Regulatory Cells(University of Regensburg)

T regulatory cells

E-selectin-targed drug carrier(Uni of Groningen, Leiden and Utrecht)

PAKISTAN INSTITUTE OF MEDICAL SCIENCES

Pakistan

PAKISTAN INSTITUTE OF LIVING AND LEARNING

Pakistan

NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES(PAKISTAN)

Pakistan

Pakistan's DRAP Launches E-Reporting System for Drug Adverse Reactions

Pakistan Approves Chinese Biosimilar Cancer Drug to Expand Access to Affordable Bevacizumab Treatment

Pakistan's HIV Surge Exposes Systemic Infection Control Failures in Healthcare Facilities